A 40something woman was thought to be too young for glaucoma but more people below age 60 are being diagnosed with glaucoma ...

Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmologyFirst ...

A population study of California Medicare patients found that high air pollution levels correlated with the risk for failure of incisional glaucoma surgery.

Glaucoma is a leading cause of irreversible blindness worldwide and often goes undiagnosed until vision loss is advanced.

Glaucoma often progresses silently, damaging vision before you even notice a problem. Experts warn that believing common myths can delay diagnosis and increase the risk of irreversible blindness.

World Glaucoma Week 2026, a global campaign by the World Glaucoma Association mobilizing five continents from March 8 ...

Artelo Biosciences (NASDAQ: ARTL) has announced its entry into the ophthalmology space with a fully funded clinical study evaluating ART27.13 in glaucoma patients. The investigator-sponsored trial ...

The 2026 Shaffer Research Grants were awarded to Kun-Che Chang, PhD, Shruthi Karnam, PhD, Kate Keller, PhD, Naoki Kiyota, MD, PhD, Gillian McLellan, PhD, Kiyoharu Miyagishima, PhD, Kerstin Nundel, PhD ...

A comanagement program at UCSF in which patients saw glaucoma-trained optometrists and had access to glaucoma specialists showed promising outcomes, according to a study published in Ophthalmology ...

India carries a significant share of the global glaucoma burden. Approximately 12 million people or more live with this disease in India, which is one of the leading causes of blindness. But almost 90 ...

Artelo Biosciences Inc (NASDAQ:ARTL) shares jumped 32.9% Wednesday following the company’s announcement of a study agreement with Belfast Health and Social Care Trust to evaluate its drug candidate ...

Store director Diana Kelly at Specsavers Linlithgow is one of just a handful of opticians across the country who have ...